Continue to Site

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

MassDevice Q&A

MassDevice Q&A: American Well CEO Roy Schoenberg

By Leave a Comment

Roy Schoenberg seems to have the gift of good timing.

The 42-year-old is CEO of American Well, a Boston-based company that’s developed a web-enabled, on-demand healthcare service so patients can speak directly to physicians at any time. The system could prove to be a low-cost solution to getting healthcare to the uninsured or under-insured — pretty fortuitous timing, when you consider Washington’s struggle to figure out a way to control spiraling healthcare costs while increasing access to care.

MassDevice Q&A: Sean Hogan

By Leave a Comment

Sean Hogan has a front-row seat for one of the great inflection points in the history of healthcare. The VP of Global Healthcare Delivery Systems for computing colossus IBM leads the development of the company’s healthcare industry solutions. Not a bad spot to be in, considering how much investment is being poured into healthcare information systems from players as diverse as Google and the U.S. government. IBM itself is looking to profit from the integration of information technology into day-to-day healthcare delivery.

MassDevice Q&A: Michael Frazzette

By Leave a Comment

After 20 years in the medical device business, you might think Smith & Nephew Endoscopy president Mike Frazzette had grown jaded. But the industry innovations, ranging from the mechanical tissue shaver that started it all for Smith & Nephew Endoscopy to current work with bioabsorbable materials, continue to amaze and engage him.

MassDevice asked Frazzette about how his endoscopy business has evolved and the way Smith & Nephew leverages its developing technologies in adjacent business segments.

MassDevice: How did you get your start in medical devices?

MassDevice Q&A: Steve Atkinson & Scott Schorer

By Leave a Comment

When Systagenix Wound Management, the former professional wound care business of Johnson & Johnson’s Ethicon subsidiary, was carved out late last year, the timing wasn’t propitious. Credit markets were frozen and the global economy was staring into an abyss with another Great Depression at the bottom.

Nearly a year later, it’s a different story. The credit crisis has eased, there are signals that the recession may be coming to an end and Systagenix is on a roll, having engineered the spinout with help from backers One Equity Partners and JP MorganChase.

MassDevice Q&A: Patrick O’Donnell

By Leave a Comment

Prochon Biotech, the Woburn, Mass.-based company that’s developing biologic knee repair technology, got its start in an unlikely sphere.

The company is leveraging its core technology, a patented fibroblast growth factor variant, grew out of research into achondroplasia, a skeletal condition that leads to so-called dwarfism.

MassDevice Q&A: William Rutan

By Leave a Comment

How do you get people to talk to their doctors about something so embarrassing they’ll barely admit it to themselves?

That’s the challenge facing Greenwich, Conn.-based medical device startup Mederi Therapeutics and the minimally invasive treatment for fecal incontinence it says will eliminate the need for drastic colostomy procedures.

MassDevice Q&A: Campbell Rogers

By Leave a Comment

Campbell Rogers, the chief scientific officer for Johnson & Johnson subsidiary Cordis Corp., knows interventional cardiology from both sides of the clinical trial.

As the former director Brigham & Women’s Hospital’s catheterization lab and principal investigator of the Brigham’s interventional vascular biology laboratory, Rogers led multi-center device and pharmacologic trials before joining Cordis in July 2006.

There he finds himself on the other side of the process as head of Cordis’ research and development team — a role the company created for him.

Mass Device Q&A: Dave Kroll

By Leave a Comment

Dave Kroll, the founder and principal of Kroll Associates, works out of his office in western Massachusetts, which, according to him, proves there is life in design and product development beyond Worcester and the Greater Boston area.

In fact, Kroll sees his distance from Boston as an advantage, since he can also tap New York, Vermont, Connecticut, New Hampshire and beyond for new work.

He has clients in and around Boston, sure — one of his biggest is in Waltham — but his ties to New England universities, contractors and manufacturers, and his persistence in maintaining a presence with clients, either virtually or through office visits, keeps him on top of the industry.

MassDevice Q&A: Charles Mathews

By Leave a Comment

Charles Mathews is no stranger to Capital Hill, having worked as a legislative aide to Reps. David Price (D-N.C.) and Rob Andrews (D-N.J) in the early years of the decade. That experience comes in handy in his role a director at Boston Healthcare Associates, where he’s keeping tabs on the ever-evolving debate over healthcare reform in Washington.

MassDevice Q&A: Dave Bergstein

By Leave a Comment

Ask Dave Bergstein about the next big thing in diagnostics and his eyes light up. The Zoíray Technologies Inc. founder and CEO runs startup that’s developing a next-generation multiplexed immunoassay platform Bergstein thinks will become the new state-of-the-art standard for studying proteins.

Copyright © 2024 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy